Mental retardation is a prominent feature of many neurodevelopmental syndromes. In an attempt to identify genetic components of these illnesses, we isolated and sequenced a large number of human genomic cosmid inserts containing large trinucleotide repeats. One of these cosmids, Cos-4, maps to the X-chromosome and contains the sequence of a 7.3-kb mRNA. Initial polymorphism analysis across a region of repetitive DNA in this gene revealed a rare 12-bp exonic variation ( 1% in non-ill males) having an increased prevalence in non-Fragile X males with mental retardation (4%, P Ͻ0.04, n = 81). This variant was not present in the highly conserved mouse homologue that has 100% amino acid identity to the human sequence near the polymorphism. Subsequent screening of two additional independent cohorts of non-Fragile X mentally retarded patients and ethnically matched controls demonstrated an even higher prevalence of the 12-bp variant in males with mental retardation (8%, P Ͻ0.0003, n = 125, and 14%, P Ͻ0.10, n = 36) vs the controls. Multivariate analysis was conducted in an effort to identify other phenotypic components in affected individuals, and the findings suggested an increased incidence of histories of hypothyroidism (P Ͻ0.001) and treatment with antidepressants (P Ͻ0.001). We conclude that the presence of this 12-bp variant confers significant susceptibility for mental retardation.
Introduction
Mental retardation (MR) affects approximately 1% of the US population with mutations in the X-chromosome estimated to cause between 30-50% of these cases. 1 The genetic mechanisms involved in a number of these X-linked syndromes have been identified and include repetitive DNA expansion in Fragile X 2 and FRAXE, 3 microdeletions, 4 and point mutations in the Mental retardation, Aphasia, Shuffling gait, and Adducted thumbs (MASA) syndrome, 5 and Corpus callosum hypoplasia, Retardation, Adducted thumbs, Spastic paraplegia and Hydrocephalus syndrome (CRASH). 6 However the causes of the majority of MR remain idiopathic at the current time.
We have genotyped a large sample of DNAs from a diverse population of mentally ill individuals with respect to a number of genomic trinucleotide repeatcontaining loci. 7 Although no large trinucleotide repeat expansions were found, a 12-bp expansion was observed in samples from several males with MR. In this report we have characterized this dodecamer expansion, as well as the surrounding DNA sequence, and we demonstrate the increased prevalence of this 12-bp expansion in non-Fragile X males with mental retardation.
Materials and methods

Isolation of Cos-4 cosmid
The cosmid library of human genomic trinucleotide repeats was constructed as previously described.
ing region was performed using standard PCR buffer (10 mM Tris-HCl (pH 8.3), 50 mM KCl, 0.001% gelatin, 2 mM MgCl 2 , 200 M of each deoxynucleotide), 0.8 M primers (Forward: CTGCTTCCTCATCCCCTGCCCTCA and Reverse: CAGGTAGCTGTTTGGACTACAGCCC) and 10% DMSO. Taq polymerase and genomic DNA concentration were 2.5 U per 100 l and 50 ng per 100 l, respectively. The thermal cycling parameters for amplification were: initial denaturation of 95°C for 5 min, then 45 cycles of 95°C for 1 min, 65°C for 30 s, and 72°C for 2 min, followed by a final extension at 72°C for 10 min. Approximately 3 l of PCR product was loaded onto a standard 6% denaturing polyacrylamide gel and electrophoresed for approximately 3 h. The separated products were electroblotted on to a N + super charged nylon membrane and the membrane then hybridized overnight to a 32 P-labeled (CTG) 10 probe and imaged using x-ray film (Kodak X-OMAT-AR). The size of the PCR product was determined by comparison to a sequencing ladder.
Isolation of cDNA and DNA sequence analysis
Probable exons in the genomic sequence in and around the Cos-4 trinucleotide repeat were identified using GRAIL (Oakridge National Laboratory). 10 Probes from putative exons were then hybridized to multi-tissue northern blots to determine the size of RNA transcripts. Based on this information, corresponding cDNAs were isolated from a lambda gt11 human heart cDNA library (Clontech, La Jolla, CA, USA). Phage DNA was prepared using a Wizard lambda prep kit (Promega, Madison, WI, USA) and sequenced using automated fluorescent methods. 9 Sequence identity comparison of the resulting data was performed using BLAST. 11 The mouse homologue of the human sequence was obtained by screening a lambda gt11 mouse heart library (Clontech) with a portion of the human sequence. Lambda DNA was then prepared and sequenced as above. Sequence analysis was conducted using the PCGENE suite of programs (Intelligenetics, Geneva, Switzerland).
Northern blots
To establish the size of transcripts and to ascertain possible alternative splicing, a 32 P-labeled 540-bp DNA segment corresponding to a region immediately 5Ј of the CAG repeat region of the cDNA was hybridized to multi-tissue northern blots (Stratagene, La Jolla, CA, USA) using Quick-Hyb™ (Stratagene).
Fluorescence in situ hybridization
The FISH procedure was carried out using 50% formamide, 10% dextran sulfate in 2 × SSC as described previously. [12] [13] [14] [15] Repetitive sequences were suppressed with 10-30 fold excess of COT-1 DNA (BRL, Gaithersburg, MD, USA). After overnight incubation, nonspecific hybridization signals were eliminated by washing the slides with 50% formamide/2 × SSC, twice with 2 × SSC, and once with 0.5 × SSC at 45°C. Specific hybridization signals were visualized using FITCconjugated Avidin (Vector Laboratories) and slides were counterstained with DAP I (4Ј-6Ј-diamino-2-phenylindole) (0.025 g ml
−1
). Only double spot signals were considered to be specific acquisition. A multi-color image analysis was used for acquisition, display and quantification of hybridization signals of metaphase chromosomes.
Human subjects
All DNA samples used in this study were collected under protocols that were approved by the appropriate institutional review boards.
Data analysis
The test statistics were generated by using either a 2 × 4 Chi-square for data using both male and female data or a 2 × 2 Chi-square when the male data were analyzed separately.
Results
The sequence of the Cos-4 repeat that was initially isolated is shown in Figure 1 AF071309) that has also been partially described by Nagase and co-workers 16 (Genbank D83783, 1996; Ross and coworkers, Genbank 80742). Previous analysis of the cDNA sequence demonstrated the presence of a DNA topoisomerase II domain and a MOPA box 17 ( Figure 2 ). Further analysis using PCGENE identified two putative transmembrane domains located from amino acid (AA) 204 to 224 and from AA 1061 to 1081. BLAST analysis did not identify any other sequence homologies at greater than 10 −6 probability. The genomic sequence for this cDNA was localized to Xq13 by FISH (figure not shown) and by radiation hybrid to Xq13 by others. 16 Northern blot analysis ( Figure 3 ) demonstrates a single 7.3-kb transcript in adult human tissues that is widely expressed, with the highest signals observed in heart, skeletal muscle, placenta and pancreas.
The corresponding mouse cDNA was also isolated. The mouse cDNA is 6580 bp in length and from the first in frame ATG encodes a protein of 2082 AA (accession No. AF071310). Compared to the human sequence the mouse sequence is 97% identical at the amino acid level (Figure 4 ) with almost half of the differences resulting from differential splicing in exon 39 (bp 5944-5976). Of particular significance is the fact that the DNA sequence flanking the 12-bp repeat in the human is completely conserved in the mouse. BLAST analysis of this sequence reveals a previously reported 594-bp sequence (M16362) spanning the MOPA domain. 17 No other matches were present at over the 10 −20 level of significance.
In the initial phase of these clinical studies, DNA from 206 non-retarded, unrelated European subjects recruited for psychiatric studies and DNA from institutionalized retarded non-Fragile X probands of mixed European ancestry (81 males and 12 females) were screened for variation in this region of DNA. A 12-bp insertion was found in samples from three males with MR while in the controls without retardation only one female heterozygote was found to have the expanded allele (Table 1 ; 4%, P Ͻ0.04 (0.04)), suggesting that the variant or expanded allele might be enriched in males with MR.
In the second phase of this study, a second larger cohort of institutionalized Caucasian non-Fragile X MR probands (115 males and 90 females) from California was compared to a cohort of Caucasian controls who were either blood bank donors (n = 125) or participants in a metabolic disease study (n = 26). The expanded allele was strongly associated with diminished cognition in males. It occurred in 8% of males in the MR cohort but not in any of the males in the control cohort (Table 1 , P Ͻ0.0003 (Ͻ 0.002)). Physical examination of the affected individuals did not reveal clear syndromal physical features. However, retrospective univariate analysis of components in the patients' histories from medical records demonstrated that the patients with the expanded allele had a much higher incidence of hypothyroidism (P Ͻ0.001; MR 3 of 9, non-MR 18 of 191) and a more frequent history of treatment with antidepressant medication (P Ͻ0.001; MR 3 of 9, non-MR 18 of 196).
In the third portion of the study, segregation analysis was performed in cohorts of non-Fragile X institutionalized mentally retarded individuals and for this cohort, anonymous medically ill Finnish 'controls' with unknown psychiatric histories referred to a tertiary care center for unknown reasons. Although it was not statistically significant, the expanded allele was found in 14% of the males with MR.
Since several of the male individuals from the Cali- Demographics of the three cohorts used in the study:
a Denotes the number of females in the study was multiplied by a factor of two to derive the number of female alleles. The Pvalues listed were generated by using a 2 × 4 Chi-square test for analyses using both male and female data or a 2 × 2 Chisquare test when the male data were analyzed separately (male only value given in parentheses). fornia sample of MR probands also had autistic features, a series of families containing male autistic probands was analyzed for the 12-bp variant. Forty-four triads of mother, father, and male proband were examined. The 12-bp variant was present in 3/44 (7%) male probands, 3/44 proband mothers, but in none (0/44) of the male probands' fathers (P Ͻ0.08).
The prevalence of this variant allele has also been examined in subjects with Hispanic, Asian and African American ancestries. Although we found the allele in both the Hispanic and African American populations, the non-random, biased nature of the samples and the absence of any appropriate MR sample cohort for comparison currently preclude any association analysis.
Discussion
This study demonstrates a significant association between an X-chromosome exonic dodecamer expansion and MR in several male Caucasian samples. However, it is not yet certain whether the expansion is causative or merely in strong linkage disequilibrium with an etiologic mutation.
If the 12-bp expansion is directly involved, the range of phenotypic manifestations is not yet clearly defined. This is not unusual in X-linked MR syndromes. 18 Indeed, the first Fragile X syndrome family 19 was originally reported as possessing a non-specific phenotype. 20 Our review of the literature suggests that the syndromic phenotype identified by us has not been previously reported. In our present study, abnormalities that were associated with the DNA expansion include MR and histories of hypothyroidism and treatment with antidepressants. This high rate of treatment of the severely affected individuals with anti-depressants and the presence of the allele in a subject recruited for psychiatric studies raises the possibility that there may be a psychiatric forme fruste component of this syndrome. Our unblinded examinations of the nonretarded Causasian male first degree relatives of the Chicago cohort of autistic males support this possibility. However, since antidepressants are commonly prescribed for indications other than depression, 21 it is not certain that affective illness is a feature of the phenotypic spectrum. In any case, prospective case control studies and a more in-depth examination of subjects will be needed before additional manifestations, such as autistic symptomology or depression, can be delineated as syndromic features.
If the 12-bp allele variant is causal for this MR syndrome then it is not fully penetrant with respect to the MR phenotype. In addition to the first degree male relatives of autistic probands noted in the Chicago cohort Autism study, there are several non-Caucasian males with the allele who may be psychiatrically ill, but do not have MR. Such incomplete penetrance has been also observed in other X-Chromosome MR syndromes including Fragile X, where approximately 20% of males carrying the mutation are unaffected 22, 23 and in FRAXE, where 45% (5/11) of individuals in a series of cases were unaffected. 24 Alternatively, given our limited physical characterization of the affected individuals, we may not have identified the full spectrum of clinical presentation. MR may not be the defining feature but rather an extreme manifestation of the affected spectrum of this syndrome.
It is possible that the association of this allele variant with MR may result from its being in linkage disequilibrium with another causative mutation. If so, given the strength of the association of the variant allele with this putative causative mutation in a broad sampling of Caucasian individuals, the disease allele must be close to the 12-bp expanded allele variant. To investigate this possibility, we are characterizing adjacent DNA segments.
An accurate determination of the prevalence of the allele in the general population would be very useful. The 12-bp allele was not observed in 151 Caucasian Americans (106 males and 45 females) referred to the NIH for non-psychiatric illnesses. However, the allele occurred in six of 94 anonymous Finnish medically ill patients with unknown psychiatric histories (42 males and 52 females). These patients, whose samples were originally gathered blindly for a serotyping study, were referred to a large tertiary care center for unknown reasons. Secondary to ethical restrictions, the psychiatric status of these individuals cannot be retrospectively assessed. The difference in these rates further emphasizes the need for prospective sampling of consecutive births to accurately determine the prevalence of the allele in various populations.
In contrast to the frequencies found for control populations, the 12-bp containing allele appears to be relatively common in the MR population. In our survey of three separate cohorts (366 patients: 232 males and 134 females), we observed the allele 19 times (17 occurring in males; 17/232 or 7%). If the 12-bp allele is responsible, at least in part for illness, our findings suggest that it may be a relatively significant genetic contribution to MR in the Caucasian population. Similarly the finding that 3/44 (7%) of the male subjects with autistic disorder had the unusual variant, suggests that it may also contribute to the development of autistic disorder, and that further studies are warranted.
The mechanism(s) through which this 12-bp variant may contribute to the development of MR is not clear. The current study demonstrates that like other genes associated with MR, such as FMR-1, 25 the Cos-4 mRNA occurs ubiquitously in adult tissues. The presence of both a DNA topoisomerase II domain in the 5Ј region and a MOPA domain, 17 the mammalian counterpart of the Drosophila OPA (odd paired) domain in the 3Ј region of Cos-4 suggests that a mutant Cos-4 gene produce could alter brain development. 26, 27 A more detailed delineation of the developmental expression of this gene in the nervous system is necessary in order to provide further insights into its role in brain development and function.
